Trial Details

Recruiting
Basic Information
Clinical ID c5446
Identifier ACTRN12621000661875
Trial Title Antibody response to COVID-19 vaccination in immunosuppressed patients with autoimmune disease
Trial URL Visit Original Page
Study Information
Study Results

NULL
Conditions Rheumatoid arthritis;Psoriatic arthritis;Ankylosing spondylitis;Crohn's Disease;Ulcerative Colitis;COVID-19;Inflammatory bowel disease; Rheumatoid arthritis Psoriatic arthritis Ankylosing spondylitis Crohn's Disease Ulcerative Colitis
Interventions Patients who are planning to have the COVID-19 vaccination will be followed. Patients having the AstraZenca vaccine will have the vaccination at weeks 0 and 12, while the patients receiving the Pfizer vaccination will receive it on weeks 0 and 4. The va
Participant Information
Sponsor Dr Ai Tran
City NULL
Country/Region Australia
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, ELDER, OLDER_ADULT
Study Design
Study Type Interventional
Phase PHASE4
Time Information
Start Date NULL
Primary Completion Date NULL
Completion Date NULL